Restricted Access
The Vault
Standardized Technical Dossiers, stability data, and clinical briefs for qualified B2B partners. All documentation reviewed and released by Morika Bio Global Quality Unit.
Product Dossiers
Complete Technical Documentation
Standardized COAs, safety data sheets, stability reports, and regulatory summaries. All documentation reviewed and released by Morika Bio Global Quality Unit.
BioSync™ Precision Yeast Synthesis
HMO Technical Dossier
Yeast-Fermented (E. coli-Free)
Zero endotoxin risk vs. legacy bacterial systems
99.9% HPLC Purity
Pharmaceutical-grade via 3rd-Gen BioSync™
pH 6.7 (Neutral Flavor Profile)
Ideal for infant formula & clinical nutrition
Legacy E. coli expression systems carry inherent endotoxin (LPS) risk requiring costly removal steps. Our BioSync™ yeast platform eliminates this contamination vector entirely.
BioSync™ Yeast Synthesis
Salidroside Technical Dossier
98% Pure (HPLC)
Highest commercial purity via precision fermentation
100% CITES-Compliant
Sustainable alternative to wild Rhodiola rosea
Zero Wild Harvesting
No heavy metal contamination from soil uptake
Wild Rhodiola rosea is listed under CITES due to overharvesting. Plant-extracted salidroside carries significant heavy metal contamination. Our fermented alternative achieves 98% purity with zero environmental impact.
37°N Signature Series
Marine Peptides Technical Dossier
<1000 Da Low Molecular Weight
Maximum bioavailability & transdermal penetration
> 90% Protein Content
High-activity enzymatic hydrolysis extraction
Thermal Stability to 180°C
Compatible with heat-processed formulations
Standardized sub-1000 Da peptides from premium 37°N ecological zone sea cucumbers. Controlled enzymatic hydrolysis preserves bioactive sequences for rapid absorption.
Technical Library
Specialized Data & Research
Beyond standard COAs: access stability testing, amino acid profiling, clinical briefs, and process documentation reviewed by Morika Bio Global Quality Unit.
Stability Testing Reports
Accelerated and real-time stability data across ICH zones I-IV. 36-month protocols for HMOs, 24-month for marine peptides.
Amino Acid Profiling
Complete amino acid composition analysis for marine peptides. Hydroxyproline quantification and peptide sequence characterization.
Clinical Briefs
Summarized pre-clinical and clinical study outcomes for salidroside anti-fatigue, HMO gut modulation, and peptide bioavailability.
Batch Analysis Trends
Quarterly batch-to-batch consistency reports across all product lines. Statistical process control data for key parameters.
Fermentation Process Briefs
BioSync™ yeast synthesis technology overview. Endotoxin-free process validation and E. coli-free pathway documentation.
Regulatory Dossiers
FDA GRAS notifications, EU Novel Food applications, CITES compliance certificates, and global market access documentation.
Verified Data
All documentation is reviewed and released by Morika Bio Global Quality Unit and verified by ISO 17025 accredited laboratories.
Confidential
Technical dossiers are shared under NDA with qualified B2B partners only. We protect your competitive intelligence.
Current Data
All specifications are updated quarterly. You will always receive the most current production data.